Psychiatry and Neurology, Neurology · Lake Charles, LA
NPI
1528158292
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
646 W McNeese St
Lake Charles, LA, 70605
Phone (337) 439-5888
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
728 services
Medicare patients, 2024
323
Average age 68
Drug cost, 2024
$4.7M
4,796 prescriptions
Company payments, 2025
$873
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reynard C Odenheimer was code 99214 (office e&m - established), 237 times for 142 patients. In total Reynard C Odenheimer billed 728 services in 30 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 237 | 142 | $74.54 | $18K |
| 95886 Electrical Nerve Conductivity | Office | 141 | 73 | $62.15 | $8,763 |
| 99213 Office E&M - Established | Office | 63 | 60 | $52.67 | $3,319 |
| 95913 Electrical Nerve Conductivity | Office | 59 | 52 | $176.61 | $10K |
| 99215 Office E&M - Established | Office | 50 | 40 | $104.27 | $5,213 |
| 99212 Office E&M - Established | Office | 45 | 45 | $25.97 | $1,169 |
| 99205 Office E&M - New | Office | 38 | 38 | $125.15 | $4,756 |
| 95910 Electrical Nerve Conductivity | Office | 23 | 22 | $104.22 | $2,397 |
By year: 2022 $89K for 919 services; 2023 $92K for 947 services; 2024 $58K for 728 services.
Medicare prescription drug claims, 2024
In 2024, the drug Reynard C Odenheimer prescribed most often to Medicare patients was Amantadine (Amantadine Hcl), with 425 prescriptions and refills. In total Reynard C Odenheimer wrote 4,796 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amantadine Amantadine Hcl | 425 | 569 | 106 | $12K |
| Propranolol Hcl Generic | 235 | 345 | 57 | $3,894 |
| Baclofen Generic | 215 | 235 | 49 | $3,383 |
| Ropinirole Hcl Generic | 196 | 263 | 47 | $3,242 |
| Oxcarbazepine Generic | 185 | 238 | 60 | $8,237 |
| Gabapentin Generic | 185 | 217 | 39 | $2,657 |
| Levetiracetam Generic | 184 | 235 | 30 | $5,904 |
| Lamotrigine Generic | 183 | 232 | 32 | $2,799 |
| Trazodone Hcl Generic | 146 | 156 | 25 | $964 |
| Carbamazepine Generic | 137 | 182 | 32 | $6,639 |
| Memantine Hcl Generic | 133 | 165 | 27 | $1,809 |
| Primidone Generic | 130 | 194 | 33 | $1,952 |
| Prednisone Generic | 128 | 135 | 35 | $512 |
| Sertraline Hcl Generic | 121 | 151 | 20 | $409 |
| Donepezil Hcl Generic | 121 | 163 | 27 | $1,987 |
Brand drugs: - claims; generic drugs: 4,386 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reynard C Odenheimer $873 ($873 in general payments such as food, travel and fees) from 11 companies. The largest payer was Neurocrine BioSciences, Inc. with $260.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 15 | $260 |
| Abbvie Inc. ABBV | 7 | $149 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $85.38 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $80.65 |
| ACADIA Pharmaceuticals Inc ACAD | 4 | $72.29 |
| Lundbeck LLC | 3 | $62.96 |
| Argenx US, Inc. ARGX | 3 | $50.9 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $43.43 |
| Mallinckrodt Hospital Products Inc. | 1 | $25.11 |
| Biogen, Inc. BIIB | 1 | $23.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.